Chair : Linda Mignone
Glycemic Variability Correlates with 1.5-anhydroglucitol (1.5-AHG) But Not with Markers of Oxidation, Inflammation, and Endothelial Function: Baseline Characteristics of the CAROLINA® Continuous Glucose Monitoring Substudy (#282)
2:00 PM
Evaluation of Blood Glucose Meter Efficacy in an Antenatal Diabetes Clinic (#284)
2:00 PM
Relationships of ‘Early’ And ‘Late’ Glycaemic Responses With Gastric Emptying During An Oral Glucose Tolerance Test In Subjects With Normal Glucose Tolerance, Impaired Glucose Tolerance And Type 2 Diabetes (#285)
2:00 PM
Depression in diabetes: ANDA findings of impact on glycaemic control (#286)
2:00 PM
Glycemic Optimisation in Cardiothoracic patients (#287)
2:00 PM
Plasma glucose in diabetes: Impact of collection tubes containing citrate stabiliser on the laboratory measurement of glucose (#288)
2:00 PM
Time-dependent effects of HbA1c levels measured through dried blood spot sampling. (#289)
2:00 PM
Response of the physiological tremor (PT) and glucose (CGMS) in type 1 diabetes during usual daily activities. (#290)
2:00 PM
Redefining the relationship between hba1c and continuous glucose monitoring system derived mean blood glucose : a longitudinal study in patients with type 2 diabetes (#291)
2:00 PM
Continuous Glucose Monitoring in Routine Clinical Practice is Not Useful in Predicting Progression to Cystic Fibrosis Related Diabetes in a Small Sized Adult Service (#292)
2:00 PM
Hypoglycaemia treatment evaluation using continuous glucose monitoring in patients without diabetes - broader application of a diabetes management tool. (#293)
2:00 PM
Discrepancies Between the Glycated Hemoglobin Criteria and Glucose-Based Criteria for Diagnosis of Diabetes and Prediabetes (#294)
2:00 PM
Glycated Hemoglobin: predictor of dyslipidemia and atherogenicity in diabetes mellitus (#295)
2:00 PM